GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
100%
nice
looking good
re rate
here we go
gap up
coming
news maybe inbound
low free float
this done 600% last time
hold on
ten trades up 20%
wow
write up from PRO ACTIVE just now'' sound good, I will post what is relevant to us''
"Today, the world needs big solutions to solve giant societal environmental problems. This joint venture is the most efficient route to deliver our world leading water technologies throughout the 23 provinces of China”, DeepVerge chief executive Gerard Brandon said in a statement.
“A joint venture with a division of one of the world's largest natural resource groups can meet the growing demand for manufacturing and assembly of existing Microtox and Microtrace equipment for environmental monitoring across the rest of the world, that is struggling to manage a global health pandemic. By partnering with China Resources we can futureproof DeepVerge as a leading innovator of smart environmental platforms with AI, equipment/devices and network management software capability", he added.
on bbc news now
Significant Shareholder % Held
Unicorn Asset Management 12.34
Jarvis Investment Management 11.83
ISPartners Investment Solutions 9.69
Hargreaves Lansdown Asset Management 9.53
Premier Miton Investors 7.93
Interative Investor 4.18
Intuitive Investments Group 4.11
Directors & Related Holdings 3.66
M D Barnard & Co 3.58
sorry wrong broad
Well, there is an opportunity that the masses haven’t cottoned onto yet.
Microsaic has some very interesting technology as it specialises in mass spectrometry. Confused? I can sympathise: ‘What the hell is that?’ was my reaction when I first came across the term ‘mass spectrometry’. That may be part of the reason many private investors have ignored it.
Allow me to explain… Mass spectrometers are designed to improve the efficiency of chemical and biological workflows. Specific applications of mass spectrometry include drug testing and discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating.
A recent agreement with DeepVerge enables Microsaic’s contamination detection equipment and services to be sold by DeepVerge’s sales network, as well as its marketing and distribution channels in the laboratory, chemical, biochemical, biofuel and biodegradable plastic and waste-water treatment industries.
Still, the development that really has me excited is the collaboration with DeepVerge to accelerate the development of the MicrotoxBT breathalyser. This ground-breaking device combines miniaturised mass spectrometry with DeepVerge’s AI data analytics to detect spike proteins of the COVID-19 virus, SARS-CoV-2, on a person’s breath. Resulting in fast, reliable, and efficient test results of the population at the point-of-need.
According to Microsaic, this platform has the potential to quickly enable GP clinics to refer serious conditions, by using biomarker binding agents capable of detecting up to 40 diseases on the human breath, including:
Cancer
Neurodegenerative conditions
Respiratory illnesses
Metabolic conditions
Well, there is an opportunity that the masses haven’t cottoned onto yet.
Microsaic has some very interesting technology as it specialises in mass spectrometry. Confused? I can sympathise: ‘What the hell is that?’ was my reaction when I first came across the term ‘mass spectrometry’. That may be part of the reason many private investors have ignored it.
Allow me to explain… Mass spectrometers are designed to improve the efficiency of chemical and biological workflows. Specific applications of mass spectrometry include drug testing and discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating.
A recent agreement with DeepVerge enables Microsaic’s contamination detection equipment and services to be sold by DeepVerge’s sales network, as well as its marketing and distribution channels in the laboratory, chemical, biochemical, biofuel and biodegradable plastic and waste-water treatment industries.
Still, the development that really has me excited is the collaboration with DeepVerge to accelerate the development of the MicrotoxBT breathalyser. This ground-breaking device combines miniaturised mass spectrometry with DeepVerge’s AI data analytics to detect spike proteins of the COVID-19 virus, SARS-CoV-2, on a person’s breath. Resulting in fast, reliable, and efficient test results of the population at the point-of-need.
According to Microsaic, this platform has the potential to quickly enable GP clinics to refer serious conditions, by using biomarker binding agents capable of detecting up to 40 diseases on the human breath, including:
Cancer
Neurodegenerative conditions
Respiratory illnesses
Metabolic conditions
it look like it is all going to kick of soon, with DVRG RNS out at the same time
that china JV is on for the microtox
HUGE NEWS FOR BOTH CO
GLA
DeepVerge will introduce Artificial Intelligence ("AI") data analytics to Microsaic's existing MS data capture capabilities to fast track the MicrotoxBT breathalyser, currently used for detecting the Spike Protein of the COVID-19 virus, SARS-CoV-2, to being able to deliver a "Point of Care" diagnostic solution at the GP's clinic. With biomarker binding agents capable of detecting up to 40 diseases on the human breath, many of which include types of cancer, neurodegenerative, respiratory and metabolic conditions, it has the potential to enable swift referral for serious conditions and at the same time reduce unnecessary doctor-to-hospital referrals and needless over-prescription of antibiotics, significantly lowering healthcare costs.
line the duck up
· Framework agreement for an initial term of three years.
· Microsaic will supply regulatory approved, CE mark, miniaturised mass spectrometry ("MS") equipment and services on a non-exclusive basis across DeepVerge's global sales, marketing and distribution channels, delivering portable solutions for healthcare diagnostic evaluation and environmental contamination detection of samples.
· Initial order by DeepVerge for three units with a total value of £100,000, plus a commitment of up to £150,000 (together, the "Orders") from DeepVerge for equipment and services to be installed at pilot facilities in DeepVerge's laboratories based in York.
· Microsaic will generate a margin on any future unit sales to DeepVerge, which DeepVerge will distribute to its underlying customers. The Directors confirm these terms are comparable to other distribution agreements the Company currently has in place.